.Pharmacolibrary.Drugs.ATC.G.G04BE09

Information

Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor, used to treat erectile dysfunction in men. It works by increasing blood flow to the penis during sexual stimulation. Vardenafil is approved and currently available as a prescription medicine in many countries.

Pharmacokinetics

Pharmacokinetics in healthy adult males following a single oral dose.

References

1. Eardley, I (2004). Vardenafil: a new oral treatment for erectile dysfunction. International journal of clinical practice 58(8) 801–806. DOI:10.1111/j.1368-5031.2004.00213.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/15372854

2. Briganti, A, et al., & Montorsi, F (2005). Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction. Nature clinical practice. Urology 2(5) 239–247. DOI:10.1038/ncpuro0186 PUBMED:https://pubmed.ncbi.nlm.nih.gov/16474835

3. Crowe, SM, & Streetman, DS (2004). Vardenafil treatment for erectile dysfunction. The Annals of pharmacotherapy 38(1) 77–85. DOI:10.1345/aph.1D019 PUBMED:https://pubmed.ncbi.nlm.nih.gov/14742800

Revisions

• 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)